Cytokinetics (CYTK) Misses Q1 EPS by 19c
Tweet
Share
E-mail
Get Alerts CYTK Hot Sheet
Price: $76.67 -1.38%
Financial Fact:
Research and development revenues from related parties: 5.57M
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
Research and development revenues from related parties: 5.57M
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
Cytokinetics (NASDAQ: CYTK) reported Q1 EPS of ($1.33), $0.19 worse than the analyst estimate of ($1.14). Revenue for the quarter came in at $840 thousand versus the consensus estimate of $1.05 million.
For earnings history and earnings-related data on Cytokinetics (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Etsy upgraded to buy at BofA on durable growth, buyback potential
- Cytokinetics Announces Upcoming Presentations at the European Society of Cardiology (ESC) Congress 2026
- LSI Industries (LYTS) Tops Q4 EPS by 3c, Beats on Revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
